NKTR Stock Price History and Quote Analysis: Insights for Investors
Nektar Therapeutics
Stock Price Today
Nektar Therapeutics (NKTR) stock surged +1.54%, trading at $1.32 on NASDAQ, up from the previous close of $1.30. The stock opened at $1.34, fluctuating between $1.29 and $1.37 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and adjuvant melanoma; phase 2 clinical trial for the treatment of renal cell carcinoma, non-small cell lung cancer, and urothelial cancer; phase 1/2A clinical trial to treat squamous cell carcinoma of the head and neck; phase 1/2 clinical trial for the treatment of solid tumors; and phase 1B clinical trial to treat COVID-19. It is also developing NKTR-358, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 1B clinical trial to treat atopic dermatitis and psoriasis; NKTR-255, an IL-15 receptor agonist, which is in phase 1/2 clinical trial for the treatment of non-Hodgkin's lymphoma and multiple myeloma, and head and neck cancer and colorectal cancer; and NKTR-262, a toll-like receptor agonist that is in phase 1/2 clinical trial to treat solid tumors, as well as various other drug candidates. The company has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Baxalta Incorporated; Eli Lilly and Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. Nektar Therapeutics was incorporated in 1990 and is headquartered in San Francisco, California.
Company Information
| Employees | 137 |
| Beta | 0.599 |
| Sales or Revenue | $90.12M |
| 5Y Sales Change% | -0.928% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Nektar Therapeutics (NASDAQ: NKTR) stock price is $1.32 in the last trading session. During the trading session, NKTR stock reached the peak price of $1.37 while $1.29 was the lowest point it dropped to. The percentage change in NKTR stock occurred in the recent session was 1.54% while the dollar amount for the price change in NKTR stock was $0.02.
The NASDAQ listed NKTR is part of Biotechnology industry that operates in the broader Healthcare sector. Nektar Therapeutics designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Jennifer Ruddock
Chief Bus. Officer
Dr. Brian L. Kotzin M.D.
Chief Medical Officer
Mr. Howard W. Robin
Chief Executive Officer, Pres & Director
Mr. John P. Northcott
Strategic Consulting Advisor
Dr. Loui T. Madakamutil
Vice President and Head of Discovery & Research
Dr. Kevin Brodbeck Ph.D.
Senior Vice President & Chief Technical Officer
Ms. Jillian B. Thomsen
Chief Financial Officer
Mr. Robert Bacci
Senior Vice President of HR & Facilities Operations
Vivian Wu
Director of Investor Relations & Corporation Affairs
Dr. Mary Tagliaferri L.Ac., M.D.
Chief Medical Officer
Dr. Jonathan Zalevsky Ph.D.
Senior Vice President & Chief R&D Officer
Ms. Sandra A. Gardiner
Executive Vice President of Fin. & Admin., Chief Financial Officer and Treasurer
NKTR's closing price is 221.95% higher than its 52-week low of $0.41 where as its distance from 52-week high of $1.93 is -31.61%.
Number of NKTR employees currently stands at 137.
Official Website of NKTR is: https://www.nektar.com
NKTR could be contacted at phone 415 482 5300 and can also be accessed through its website. NKTR operates from 455 Mission Bay Boulevard South, San Francisco, CA 94158, United States.
NKTR stock volume for the day was 784.91K shares. The average number of NKTR shares traded daily for last 3 months was 1.06M.
The market value of NKTR currently stands at $242.98M with its latest stock price at $1.32 and 184.08M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com